OOIR: Observatory of International Research

Papers

(The TQCC of Nature Reviews Urology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Sexual recovery interventions following prostate cancer treatment	182
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything	167
Texture analysis for patient selection	143
Single-cell and spatial sequencing of kidney cancer	115
Exploratory results from the CheckMate 214 trial	96
Human-relevant urothelial model provides insight into infection strategies and host response	76
Krause corpuscles act as genital vibration detectors	68
Semen quality recovery following COVID-19	65
Immune infiltration associated with outcomes	65
PARP inhibitors plus enzalutamide to treat mCRPC	64
Time for women-centred gynaecology	64
Urine microbiota differ in bladder cancer	62
Top, bottom or vers? Creating a more equitable health system for sexual and gender minority patients with prostate cancer	62
High-dose chemotherapy for relapsed testicular germ cell tumours	60
Advancing the state of the art in congenital obstructive uropathy	58
Considering urology in a planetary context	57
Implementation of patient-reported outcome measures into health care for men with localized prostate cancer	56
Preclinical models of bladder cancer: BBN and beyond	53
Micro-ultrasound for prostate cancer	53
A clinical guide to rare male sexual disorders	51
FOXA2–KIT-driven lineage plasticity in NEPC	49
Proteomic-based analysis of testicular interstitial fluid	49
Prevalence of gender dysphoria in Japan	49
A new text message-based platform for self-management of patients with IC/BPS	47
Overcoming antibiotic resistance in complicated UTI	45

Promise without practice — charting the path forward for bladder cancer biomarkers	44
Madrid plays host to a celebration of urology	42
Microfluidic sperm selection	42
What happens in Vegas … shapes the future of urology	42
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations	40
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers	39
Reducing the stigma of academic mental health can save lives	39
Is SARS-CoV-2-induced testicular damage in hamsters relevant?	39
Metaverse in surgery — origins and future potential	38
Galectins as potential therapeutic targets in STIs in the female genital tract	37
Evolution of the World Health Organization semen analysis manual: where are we?	37
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence	37
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer	37
Pembrolizumab + axitinib beyond first-line therapy for mRCC	36
COVID can’t kill CopMich collaboration	35
A non-invasive assay for UTUC diagnosis	35
Vaccination to prevent untreatable gonorrhoea	34
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment	34
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications	33
Resolving the puzzle of same-sex sexual interactions	33
Efficacy of the Revi system in treating urgency urinary incontinence	33
Personalized 3D models for prostate cancer surgery	32
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway	31
PEACEing together prostate cancer therapy	31
The mechanism of action of neuromodulation in the treatment of overactive bladder	31
Persistent Müllerian duct syndrome — a rare but important cause of male factor infertility	31
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology	29
Sexual orientation, gender identity and COVID: a complicated picture	28
Measuring and improving the cradle-to-grave environmental performance of urological procedures	28
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC	27
Secondary kidney stones — remove or leave?	27
Effect of high glucose on E. coli	27
The magic of MagSToNE	27
Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy?	27
Cribriform morphology affects mpMRI imaging	26
Women in urology: the past	25
AUA returns to its former glory in Chicago	24
Promising efficacy of UTI vaccines as an alternative to antibiotics	24
A distinct TAM subset mediates immunotherapy resistance in prostate cancer	24
Successful mentorship for women in urology — a new era	24
Prostate cancer in transgender women — challenges in research and clinical care	24
Excluding PLND in favourable intermediate-risk prostate cancer: a PSMA-PET-directed perspective	23
Robots learning to imitate surgeons — challenges and possibilities	22
Is it time to rethink the current patient-reported outcome measures?	22
Microultrasonography-guided prostate cancer biopsy	21
The placebo and nocebo effects in functional urology	20
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease	18
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards	18
Current and emerging strategies to curb antibiotic-resistant urinary tract infections	17
Androgen receptor pathway inhibitor combination in prostate cancer	16

Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer	16
Going in circles: circMGA–HNRNPL feedback loop in bladder cancer	16
A clinical overview of people living with HIV and genitourinary cancer care	16
Metabolic response to immunotherapy in prostate cancer	16
Videourodynamics — role, benefits and optimal practice	16
Pride, not prejudice	15
De-clear cell differentiated renal cell carcinoma — a new therapeutic target	15
Management and cost of stent encrustation in pregnancy	15
AI for antibiotic design	15
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer	15
The future of patient-derived xenografts in prostate cancer research	14
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD	14
Turning up the heat: CTLA4 blockade in urothelial cancer	13
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective	13
The evolving treatment landscape of metastatic urothelial cancer	13
The value of women urologists — individual and institutional imperatives to address salary equity	12
Immune-based therapies in penile cancer	12
Turning back time in the testes	12
We all get erections — de-gendering sexual arousal dysfunction in the ICD	12
Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning	12
Uncovering a link between COVID-19 and renal cell carcinoma	12
The prognostic role of stroma in UTUC	12
Pelvic-fascia-sparing techniques and outcomes with RARP	11
The shifting treatment paradigm of metastatic renal cell carcinoma	11
New evidence and novel techniques for assessing intraoperative margins during radical prostatectomy	11
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself	11
Current and future pharmacotherapy for female sexual dysfunction	11
Improved phenotypic classification of male infertility to promote discovery of genetic causes	11
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome	10
Hallmark discoveries in the biology of Wilms tumour	10
Men hold the balance of power	10
The unclear role of PET–CT in localized radiorecurrent prostate cancer	10
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer	10
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer	9
BAUSing back in Birmingham	9
Power up to investigate PrEP	9
Tuft cells in prostate cancer	9
Effects of COVID-19 vaccine on semen parameters	9
Diagnosis of ccRCC	9
Patient selection is key in IMbassador250	9
CMA mediates resistance to androgen inhibitors in prostate cancer	9
Mellow yellow: BilR reduces bilirubin to urobilinogen	8
Male infertility and somatic health — insights into lipid damage as a mechanistic link	8
Semen parameters across testicular cancer stages	8
Microbiota manipulation to prevent oxalate kidney stone formation	8
Spatiotemporal trends in human semen quality	8
Author Correction: Atypical intraductal proliferation in prostate biopsy — a diagnostic grey zone with clinical implications	8
Metabolism, mitochondria and metastasis in kidney cancer	8
Mechanisms of the intestinal and urinary microbiome in kidney stone disease	8
A prompt-based stewardship to reduce extended-spectrum antibiotic treatment in UTI	8
Advances in sliding clip renorrhaphy for partial nephrectomy	7
MRI diagnosis and radical prostatectomy outcomes	7
Testosterone replacement therapy and spermatogenesis in reproductive age men	7
Stepping up to prevent bacterial vaginosis recurrence	7
The ins and outs of penile erection	7
Chlorination by-products in drinking water — association with bladder cancer risk	7
Pronouns in English: a user’s guide	7
Syphilis on the rise — a need for alternative therapies and vaccines	6
Prostate luminal progenitor cells: from mouse to human, from health to disease	6
Artificial intelligence in the management of prostate cancer	6
Clinical trial design for non-muscle-invasive bladder cancer	6
Feasibility and potential of an MRI-based prostate cancer screening	6
Sperm activity affected by endometriosis	6
Particulate matter leaves a bitter taste in testes	6
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS	6
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma	6
The effects of diet on prostate cancer outcomes	6
Visual clues — dermatological manifestations of sexually transmitted infections in men	6
Toilet-based continuous health monitoring using urine	6
A great gathering at the 4th Clinical and Scientific Advances in UTI conference	6
Urology on a changing planet: links between climate change and urological disease	6
Genetic and biological drivers of prostate cancer disparities in Black men	6
Influence of substance use on male reproductive health and offspring outcomes	6